Neutrophil infiltration and oxidant-production in human atherosclerotic carotid plaques

Histology and Histopathology

Volumn 26, Issue 1, 2011, Pages 1-11

  Hosokawa, Takatoshi ^a   Kumon, Yoshitaka ^a   Kobayashi, Toshihiro ^a   Enzan, Hideaki ^a   Nishioka, Yutaka ^b   Yuri, Kazunari ^c   Wakiguchi, Hiroshi ^a   Sugiura, Tetsuro ^a  

^a KOCHI UNIVERSITY   (Japan)

^b KOBE INTERNATIONAL UNIVERSITY   (Japan)

^c Chikamori Hospital   (Japan)

Author keywords

Inflammation; N formyl peptide receptor like 1 (fPRL1); Neutrophil; Rupture of human atherosclerotic plaque; Serum amyloid A

Indexed keywords

CD68 ANTIGEN, HUMAN; CEACAM8 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CYBA PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; FORMYLPEPTIDE RECEPTOR; FPR2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; LIPOXIN RECEPTOR; NAPHTHOL AS D ESTERASE; OXIDIZING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AGED; ARTICLE; ATHEROSCLEROSIS; BIOSYNTHESIS; CAROTID ARTERY OBSTRUCTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; CAROTID STENOSIS; CELL ADHESION MOLECULES; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MALE; MIDDLE AGED; NADPH OXIDASE; NAPHTHOL AS D ESTERASE; NEUTROPHIL INFILTRATION; NEUTROPHILS; OXIDANTS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 78651243443     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Almkvist A., Fäldt J., Dahlgren C., Leffler H. and Karlsson A. (2001). Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe. Infect. Immun. 69, 832-837.
2. phox in human coronary arteries. Circulation 100, 1494-1498.
3. Boldt K., Rist W., Weiss S. M., Weith A. and Lenter M. C. (2006). FPRL-1 induces modifications of migration-associated proteins in human neutrophils. Proteomics 6, 4790-4799.
4. Brown D. L., Hibbs M. S., Kearney M., Loushin C. and Isner J. M. (1995). Identification of 92-kD gelatinase in human coronary atherosclerotic lesions association of active enzyme synthesis with unstable angina. Circulation 91, 2125-2131.
5. Bylund J., Karlsson A., Boulay F. and Dahlgren C. (2002). Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp (2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70, 2908-2914.
6. Bylund J., Samuelsson M., Collins L. V. and Karlsson A. (2003). NADPHoxidase activation in murine neutrophils via formyl peptide receptors. Exp. Cell Res. 282, 70-77.
7. Carp H. (1982). Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155, 264-275.
8. Faurschou M., Borregaard N. (2003). Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 14, 1317-1327.
9. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A. and Dahlgren C. (2006). Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79, 247-256.
10. Gach O., Nys M., Deby-Dupont G., Chapelle J. P., Lamy M., Piérard L. A. and Legrand V. (2006). Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients. Int. J. Cardiol. 112, 59-65.
11. Gerrity R. G. (1981a). The role of the monocyte in atherogenesis I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103, 181-190.
12. Gerrity R. G. (1981b). The role of the monocyte in atherogenesis II. Migration of foam Cclls from atherosclerotic lesions. Am. J. Pathol. 103, 191-200.
13. Guzik T. J., Sadowski J., Guzik B., Jopek A., Kapelak B., Przybylowski P., Wierzbicki K., Korbut R., Harrison D. G. and Channon K. M. (2006). Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26, 333-339.
14. Hansson G. K. (2001). Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 1876-1890.
15. Hansson G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695.
16. Hirai K., Moriguchi K. and Wang G. Y. (1991). Human neutrophils produce free radicals from the cell-zymozan interface during phagocytosis and from the whole plasma membrane when stimulated with calcium ionophore A23187. Exp. Cell Res. 194, 19-27.
17. Jonasson L., Holm J., Skalli O., Bondjers G. and Hansson G. K. (1986). Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131-138.
18. Kobayashi T. and Robinson J. M. (1991). A novel intracellular compartment with unusual secretory properties in human neutrophils. J. Cell Biol. 113, 743-756.
19. Kobayashi T., Garcia del Saz E., Hendry J. and Seguchi H. (1999). Detection of oxidant producing-sites in glutaraldehyde-fixed human neutrophils and eosinophils stimulated with phorbol myristateacetate. Histochem. J. 31, 181-194.
20. Kumamoto M., Nakashima Y. and Sueishi K. (1995). Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum. Pathol. 26, 450-456.
21. Kumon Y., Suehiro T., Hashimoto K. and Sipe J. D. (2001). Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid A gene expression and production by cultured human aortic smooth muscle cells. Scand. J. Immunol. 53, 7-12.
22. Kumon Y., Hosokawa T., Suehiro T., Ikeda Y., Sipe J. D. and Hashimoto K. (2002). Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells. Amyloid 9, 237-241.
23. Leclercq A., Houard X., Philippe M., Ollivier V., Sebbag U., Meilhac O. and Michel J. B. (2007). Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J. Leukoc. Biol. 82, 1420-1429.
24. Migeotte I., Communi D. and Parmentier M. (2006). Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17, 501-519.
25. Miller F. J. Jr, Gutterman D. D., Rios C. D., Heistad D. D. and Davidson B. L. (1998). Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82, 1298-1305.
26. Moreno P. R., Purushothaman K. R., Sirol M., Levy A. P. and Fuster V. (2006). Neovascularization in human atherosclerosis. Circulation 113, 2245-2252.
27. Naruko T., Ueda M., Haze K., van der Wal A. C., van der Loos C. M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., Ehara S., Yoshiyama M., Takeuchi K., Yoshikawa J. and Becker A. E. (2002). Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106, 2894-2900.
28. Nijm J., Wikby A., Tompa A., Olsson A. G. and Jonasson L. (2005). Circulating levels of proinflammatory cytokines and neutrophilplatelet aggregates in patients with coronary artery disease. Am. J. Cardiol. 95, 452-456.
29. Ohara E., Kumon Y., Kobayashi T., Takeuchi H. and Sugiura T. (2007). Exocytosis of neutrophil formyl peptide receptor-like 1 (fPRL1) results in downregulation of cytoplasmic fPRL1 in patients with purulent dermatitis. Clin Vaccine Immunol. 14, 678-684.
30. Okada T., Kobayashi T., Hakoi K. and Seguchi H. (1987). A simple method for light microscopical visualization of phosphohydrolase activities in materials processed for cerium based ultracytochemistry. Acta Histochem. Cytochem. 20, 105-110.
31. Rabiet M. J., Huet E. and Boulay Fx. (2005). Human mitochondriaderived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur. J. Immunol. 35, 2486-2495.
32. Reape T. J. and Groot P. H. (1999). Chemokines and atherosclerosis. Atherosclerosis. 147, 213-225.
33. Schaffne T., Taylor K., Bartucci E. J., Fischer-Dzoga K., Beeson J. H., Glagov S. and Wissler R. W. (1980). Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100, 57-80.
34. Selvatici R., Falzarano S., Mollica A. and Spisani S. (2006). Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 534, 1-11.
35. Stary H. C., Chandler A. B., Glagov S., Guyton J. R., Insull W., Rosenfeld M. E., Schaffer S. A., Schwartz C. J., Wagner W. D. and Wissler R. W. (1994). A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 14, 840-856.
36. Stary H. C., Chandler A. B., Dinsmore R. E., Fuster V., Glagov S., Insull W., Rosenfeld M. E., Schwartz C. J., Wagner W. D. and Wissler R. W. (1995). A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15, 1512-1531.
37. Su S. B., Gong W., Gao J. L., Shen W., Murphy P. M., Oppenheim J. J. and Wang J. M. (1999). A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
38. van der Wal A. C., Becker A. E., van der Loos C. M. and Das P. K. (1994). Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36-44.
39. Yokota J., Takuma D., Hamada A., Onogawa M., Yoshioka S., Kusunose M., Miyamura M., Kyotani S. and Nishioka Y. (2006). Scavenging of reactive oxygen species by Eriobotrya japonica seed extract. Biol. Pharm. Bull. 29, 467-471.